Skip to content

Exploring the neural mechanisms at the individual level where mutations in the ATP7B gene lead to abnormal brain functional-structural expression in Wilson's disease system of research

Exploring the neural mechanisms at the individual level where mutations in the ATP7B gene lead to abnormal brain functional-structural expression in Wilson's disease system of research

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120844
Enrollment
Unknown
Registered
2026-03-20
Start date
2022-05-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with WD hepatic type, 5WD cerebral type patients

Interventions

WD hepatic group:None
Normal Control Group:None
WD Neurological group:None

Sponsors

Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Wilson's Disease Group (WD) : 1. All WD patients must have a Leipzig score >= 4 points. 2.? Grouping method: Patients are classified by senior neurologists (attending physicians or higher) based on clinical manifestations into ?hepatic type? (predominant liver impairment) or ?neurological type? (predominant brain damage). Normal Control Group ?Criteria: Healthy controls matched with WD patients in terms of sex, age, and education level. ?Additional requirements: Aged 18–30 years; Right-handed; No history of neurological or psychiatric disorders.

Exclusion criteria

Exclusion criteria: 1. Severe neuropsychiatric symptoms; 2. Eligible patients with severe liver disease (Child-Pugh score of D); 3. The amplitude of head movement is too large to cooperate with the completion of MRI examination; 4. Those who are contraindicated to MRI examination.

Design outcomes

Primary

MeasureTime frame
Resting-state head MRI;specificity;sensitivity;Area under the ROC curve;

Secondary

MeasureTime frame
Heart Rate, Blood Pressure;Kayser-Fleischer (K-F) Rings;

Countries

China

Contacts

Public ContactYunfan Wu

Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)

wuyunfan2007@163.com+86 15818102915

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026